目的:检测急性淋巴细胞白血病细胞(acute lymphoblastic leukemia,ALL)CCRF-CEM和Raji细胞中Beta-抑制蛋白1(Beta-Arrestin1)与Zeste增强子同源物-2蛋白(enhancer of Zeste homolog 2,EZH2)是否存在结合。方法:白血病细胞中,Western blot检测Beta-Arrestin1与EZH2表达水平,激光共聚焦(Confocal)检测 Beta-Arrestin1与EZH2在细胞中的位置与共定位;免疫共沉淀(CO-IP)检测Beta-Arrestin1与EZH2结合能力。结果:Beta-Arrestin1与EZH2在白血病K562、CCRF-CEM和Raji细胞中均有表达。激光共聚焦结果显示Beta-Arrestin1与EZH2均在K562、CCRF-CEM和Raji细胞内共定位,CO-IP结果显示在K562,CCRF-CEM和Raji细胞中Beta-Arrestin1与EZH2结合。结论:在CCRF-CEM和Raji中,Beta-Arrestin1可与EZH2结合。
Abstract
Objective:To test that if Beta-Arrestin1 could bind with enhancer of Zeste homolog 2(EZH2) in acute lymphoblastic leukemia(ALL) CCRF-CEM and Raji cells. Methods:The protein levels of Beta-Arrestin1 and EZH2 in the leukemia cells were determined by Western blot. The location of Beta-Arrestin1 and EZH2 in the leukemia cells was measured by confocal microscopy. Co-immunoprecipitation(CO-IP) was examined for the binding of Beta-Arrestin1 with EZH2 in leukemia cells. Results:Western blot results showed that b/Beta-Arrestin1 and EZH2 expressed in those three leukemia cells. Confocal data showed the colocaliza-tion of Beta-Arrestin1 and EZH2 in K562,CCRF-CEM and Raji cells. CO-IP assay illustrated that Beta-Arrestin1 bind with EZH2 in three leukemia cells. Conclusion:Beta-Arrestin1 could bind to EZH2 in ALL CCRF-CEM and Raji cells.
关键词
白血病Beta-抑制蛋白1Zeste增强子同源物-2蛋白蛋白结合
Keywords
leukemiaBeta-Arrestin1enhancer of Zeste homolog 2protein-protein interaction
Factors affecting the quality of life in children with leukemia and the relevant research progress at home and abroad
Effect of artesunate on autophagy of leukemic K562 cells and its mechanism
RCIA AND RBC SOD ACTIVITY IN PATIENTS WITH LEUKEMIA AND MALIGNANT LYMPHOMA
DETERMINATION OF ACUTE PROTEIN AND SIALIC ACID IN PATIENTS WITH ACUTE LEUKEMIA
MORPHOLOGICAL AND IMMUNOPHENOTYPICSTUDIES ON ACUTE LEUKEMIA
Related Author
Shi Lin
Mo Lin
He Yun
Liu Yang
Wang Zijuan
Zhang Ping
Yang Guicun
Chen Hongxia
Related Institution
the Third Surgical Ward,the Children’s Hospital,Chongqing Medical University
Special Needs Outpatient,the Children’s Hospital,Chongqing Medical University
Department of Hematology,the Children’s Hospital,Chongqing Medical University,Ministry of Education Key Laboratory of Child Development and Disorders,China International Science andTechnology Cooperation Base of Child Development and Critical Disorders,Chongqing Key Laboratory of Pediatrics